Skip to main content

Table 1 Demographics of patients (n = 140)

From: Circulating anti-citrullinated peptide antibodies, cytokines and genotype as biomarkers of response to disease-modifying antirheumatic drug therapy in early rheumatoid arthritis

 

n or median

% or IQR

Black ethnicity (%)

124.0

88.5

Females (%)

110.0

79.2

Age in years, median (IQR)

47.8

14.4

Symptom duration in months, median (IQR)

9.7

11.4

Smoking history (%)

34.0

24.2

Nodulosis (%)

27.0

19.3

Rheumatoid factor positive (%) IU/ml

114.0

81.4

ACPA [n at baseline = 126] (%) U/ml

106.0

84.1

Shared Epitope positive [n at baseline =115] (%)

106.0

92.1

CRP baseline,median (IQR) μg/ml

17.1

42.3

SDAI baseline, median (IQR)

41.4

24.1